Fresenius Medical Care AG & Co. KGaA (FMS) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
Else-KrOener Strasse 1
Bad Homburg, 61352
Germany
Phone
49 6172 608 2522
Sector
Healthcare
Industry
Medical - Care Facilities
Employees
112035
First IPO Date
September 17, 1996
| Name | Title | Pay | Year Born |
| Joseph E. Turk Jr. | Chief Executive Officer of Care Enablement & Member of Management Board | 3.71M | 1968 |
| Craig Cordola FACHE | Chief Executive Officer of Care Delivery & Member of Management Board | 3.73M | 1972 |
| Helen Giza | Chair of Management Board & Chief Executive Officer | 4.32M | 1968 |
| Jorg Haring | Member of the Management Board, Global Head of Legal,Compliance & Human Resources and Labor Director | 1.89M | 1970 |
| Martin Fischer | Chief Financial Officer & Member of the Management Board | 2.5M | 1978 |
| Charles Hugh-Jones | Global Chief Medical Officer & Member of Management Board | 3.12M | 1970 |
| Glenn Slater | Senior Vice President of Manufacturing and Supply Chain Operations | 0 | N/A |
| Joachim Weith | Senior Vice President of Corporate Communications & Governmental Affairs | 0 | N/A |
| Dominik Heger | Executive Vice President and Head of Investor Relations, Strategic Development & Communications | 0 | N/A |
| Gail-Suzanne Brown | Senior Vice President of Research & Development | 0 | N/A |
Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Through an extensive network of outpatient clinics, it delivers essential dialysis therapy along with laboratory and diagnostic support. For home-based care, the company supplies necessary equipment, provides comprehensive training, and offers ongoing patient assistance, including clinical oversight and coordinating supply deliveries directly to patients. In the United States, Fresenius Medical Care also contracts with hospitals to provide vital dialysis interventions for hospitalized individuals suffering from end-stage renal disease (ESRD) and acute kidney failure. Beyond services, it is a prominent developer, manufacturer, and distributor of a broad range of dialysis products. This portfolio encompasses polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers and solutions, concentrates, bloodlines, renal pharmaceuticals, and water treatment systems. Additionally, the company produces non-dialysis medical devices, including acute cardiopulmonary and apheresis products. Its pharmaceutical division focuses on developing, acquiring, and in-licensing specialized renal medications, distributing these essential drugs and supplies to both individual patients' homes and dialysis centers. The company also extends its medical offerings to include a variety of specialized services such as vascular, cardiovascular, and endovascular care, operating ambulatory surgery centers for vascular procedures, and providing physician services in nephrology and cardiology. Products are sold directly to dialysis clinics, hospitals, and specialized treatment centers, complemented by sales through local teams, independent distributors, dealers, and agents. By February 23, 2022, Fresenius Medical Care managed an impressive network of 4,171 outpatient dialysis clinics across roughly 150 countries. Established in 1996, the company maintains its headquarters in Bad Homburg, Germany.